Alimera Sciences Valuation
| ALIM Stock | USD 3.55 0.03 0.84% |
At this time, the firm appears to be undervalued. Alimera Sciences shows a prevailing Real Value of $4.24 per share. The current price of the firm is $3.55. Our model approximates the value of Alimera Sciences from analyzing the firm fundamentals such as Profit Margin of (0.25) %, current valuation of 240.68 M, and Return On Equity of -1.59 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Alimera Sciences' valuation include:
Price Book 4.0028 | Enterprise Value 240.7 M | Enterprise Value Ebitda (213.52) | Price Sales 2.2821 | Forward PE 117.6471 |
Undervalued
Today
Please note that Alimera Sciences' price fluctuation is moderately volatile at this time. Calculation of the real value of Alimera Sciences is based on 3 months time horizon. Increasing Alimera Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Alimera Sciences is useful when determining the fair value of the Alimera stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Alimera Sciences. Since Alimera Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alimera Stock. However, Alimera Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.55 | Real 4.24 | Target 7.0 | Hype 3.56 | Naive 3.62 |
The real value of Alimera Stock, also known as its intrinsic value, is the underlying worth of Alimera Sciences Company, which is reflected in its stock price. It is based on Alimera Sciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Alimera Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alimera Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alimera Sciences helps investors to forecast how Alimera stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alimera Sciences more accurately as focusing exclusively on Alimera Sciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Alimera Sciences' intrinsic value based on its ongoing forecasts of Alimera Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Alimera Sciences' closest peers. When choosing an evaluation method for Alimera Sciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Alimera Sciences Investments |
|
Alimera Valuation Trend
Knowing Alimera Sciences' actual value is paramount for traders to make sound investment determinations. Alimera Sciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Alimera Sciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Alimera Sciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Alimera Market Cap
Alimera Sciences is rated third in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 9.36 Billion. Alimera Sciences holds roughly 187.43 Million in market capitalization claiming about 2.0% of equities under Health Care industry.Alimera Sciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Alimera Sciences's current stock value. Our valuation model uses many indicators to compare Alimera Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alimera Sciences competition to find correlations between indicators driving Alimera Sciences's intrinsic value. More Info.Alimera Sciences is rated second in price to earning category among related companies. It is rated second in price to book category among related companies fabricating about 2.43 of Price To Book per Price To Earning. As of the 18th of April 2024, Price To Book Ratio is likely to grow to 2.51. Comparative valuation analysis is a catch-all model that can be used if you cannot value Alimera Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Alimera Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alimera Sciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Alimera Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Alimera Sciences and how it compares across the competition.
About Alimera Sciences Valuation
The stock valuation mechanism determines the current worth of Alimera Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Alimera Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Alimera Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Alimera Sciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Alimera Sciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alimera Sciences. We calculate exposure to Alimera Sciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alimera Sciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 61.2 M | 32.6 M | |
| Pretax Profit Margin | (0.25) | (0.26) | |
| Operating Profit Margin | (0.02) | (0.02) | |
| Net Loss | (0.25) | (0.26) | |
| Gross Profit Margin | 0.76 | 0.63 |
8 Steps to conduct Alimera Sciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Alimera Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Alimera Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Alimera Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Alimera Sciences' revenue streams: Identify Alimera Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Alimera Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Alimera Sciences' growth potential: Evaluate Alimera Sciences' management, business model, and growth potential.
- Determine Alimera Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Alimera Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Alimera Sciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Alimera Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.6 M | |
| Forward Price Earnings | 117.6471 |
Alimera Sciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Alimera Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Alimera we look at many different elements of the entity such as Alimera's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Alimera Sciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alimera Sciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alimera Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alimera Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alimera Sciences' worth.When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Alimera Stock analysis
When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Revenue Per Share 3.159 | Quarterly Revenue Growth 0.875 | Return On Assets (0.01) | Return On Equity (1.59) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.